Regeneron Pharma (REGN) PT Lowered to $1,030 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $1,030.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
